Managing the non-surgical aspect of comanagement
August 19th 2014The lines between a surgical management and non-surgical management are more defined in states where surgery is performed by only ophthalmologists. However, the non-surgical management of our patients can be a little blurred and subject to your own personal acumen.
Rebutting mesozeaxanthin findings
August 19th 2014We read with interest, and some surprise, Dr. Stuart Richer’s article in Optometry Times entitled “The third carotenoid-mesozeaxanthin (Z-RS) and who needs to consume it.” In this article, Dr. Richer concludes that “simple proclamations...are misleading,” and we concur with his conclusion in this regard
How digital devices are affecting vision
August 18th 2014If I were to say to you, “My patient is suffering from DES,” what would be your initial thought? Dry eye syndrome? Possibly. However, now more than ever, we are seeing more and more patients suffering from digital eye strain. Let’s face it: we live in a digital world.
AMD patients respond to aflibercept treatment
August 14th 2014A study recently published in the British Journal of Ophthalmology found that patients with exudative age-related macular degeneration (AMD) who were incomplete responders to multiple ranibizumab injections (Lucentis, Genentech) saw improvements with aflibercept (Eylea, Regeneron) treatment.